Recent Research Analysts’ Ratings Changes for Envista (NVST)

Several analysts have recently updated their ratings and price targets for Envista (NYSE: NVST):

• 12/16/2025 – Envista had its price target raised by analysts at JPMorgan Chase & Co. from $20.00 to $22.00. They now have a “neutral” rating on the stock.
• 12/15/2025 – Envista had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 12/8/2025 – Envista is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $24.00 price target on the stock.
• 12/8/2025 – Envista had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 12/8/2025 – Envista is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $24.00 price target on the stock.
• 12/1/2025 – Envista had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 11/24/2025 – Envista had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 11/17/2025 – Envista had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 11/11/2025 – Envista had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 11/5/2025 – Envista had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 11/3/2025 – Envista was given a new $19.00 price target on by analysts at Mizuho.
• 11/1/2025 – Envista was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating.
• 10/31/2025 – Envista was given a new $27.00 price target on by analysts at Robert W. Baird.
• 10/31/2025 – Envista had its “outperform” rating reaffirmed by analysts at Evercore ISI.
• 10/30/2025 – Envista was given a new $25.00 price target on by analysts at Stifel Nicolaus.

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.